Copper Catalysis in Living Systems and In Situ Drug Synthesis
Authors:
- 15 November 2016
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 128 (50) , 15891-15895
Abstract
The copper‐catalyzed azide–alkyne cycloaddition (CuAAC) reaction has proven to be a pivotal advance in chemical ligation strategies with applications ranging from polymer fabrication to bioconjugation. However, application in vivo has been limited by the inherent toxicity of the copper catalyst. Herein, we report the application of heterogeneous copper catalysts in azide–alkyne cycloaddition processes in biological systems ranging from cells to zebrafish, with reactions spanning from fluorophore activation to the first reported in situ generation of a triazole‐containing anticancer agent from two benign components, opening up many new avenues of exploration for CuAAC chemistry.Keywords
This publication has 48 references indexed in Scilit:
- Building better bioorthogonal reactionsCurrent Opinion in Chemical Biology, 2014
- Bringing chemistry to lifeNature Methods, 2011
- Pharmacological significance of triazole scaffoldJournal of Enzyme Inhibition and Medicinal Chemistry, 2010
- Bioorthogonal chemistry: recent progress and future directionsChemical Communications, 2010
- Chemistry in living systemsNature Chemical Biology, 2005
- Copper toxicity, oxidative stress, and antioxidant nutrientsToxicology, 2003
- A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal AlkynesAngewandte Chemie International Edition, 2002
- A Stepwise Huisgen Cycloaddition Process: Copper(I)?Catalyzed Regioselective “Ligation” of Azides and Terminal Alkynes†Angewandte Chemie, 2002
- Click-Chemie: diverse chemische Funktionalität mit einer Handvoll guter ReaktionenAngewandte Chemie, 2001
- Click Chemistry: Diverse Chemical Function from a Few Good ReactionsAngewandte Chemie International Edition, 2001